Thorne HealthTech, Inc. (THRN) Tops Q2 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St on pace for higher open as oil pulls back ahead of Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts THRN Hot Sheet
Join SI Premium – FREE
Thorne HealthTech, Inc. (NASDAQ: THRN) reported Q2 EPS of $0.15, $0.09 better than the analyst estimate of $0.06. Revenue for the quarter came in at $72.7 million versus the consensus estimate of $68.41 million.
GUIDANCE:
Thorne HealthTech, Inc. sees FY2023 EPS of $0.26-$0.32, versus the consensus of $0.29. Thorne HealthTech, Inc. sees FY2023 revenue of $285-290 million, versus the consensus of $282 million.
For earnings history and earnings-related data on Thorne HealthTech, Inc. (THRN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Pentair (PNR) Tops Q3 EPS by 10c, Beats on Revenue; Offers FY26 EPS Guidance
- First Financial (THFF) Tops Q3 EPS by 28c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
